Get notified when XNCR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRisk Profile Improvements
- Material Weakness (removed) — Prior material weaknesses in disclosure controls and procedures have been remediated; current filing states controls are effective.
Xencor settles Alexion royalty dispute; Q2 revenue +17.5% to $51.2M
Filed August 5, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 6, 2025 · ~1 min read
Key Changes
-
high
Alexion dispute settled for $105M in two installments; Alexion will no longer pay U.S. Ultomiris royalties going forward.
MD&A: Alexion settlement verify on EDGAR → -
high
Net loss narrowed 29.5% to -$21.7M despite operating loss widening 12% to -$37.1M
Key Financials view on EDGAR → -
high
Cash and marketable securities fell to $486.4M from $610.8M at year-end; runway extended through 2028.
MD&A: Liquidity verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ESTC 10-Q) is open in full — no account needed.
Partner
Trade XNCR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify